RZH
Relyea Zuckerberg Hanson’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $323K | Buy |
13,331
+3,825
| +40% | +$92.7K | 0.04% | 204 |
|
|
2025
Q1 | $241K | Sell |
9,506
-1,196
| -11% | -$30.3K | 0.03% | 233 |
|
|
2024
Q4 | $284K | Sell |
10,702
-4,548
| -30% | -$121K | 0.04% | 216 |
|
|
2024
Q3 | $441K | Buy |
15,250
+1,904
| +14% | +$55.1K | 0.07% | 149 |
|
|
2024
Q2 | $373K | Buy |
13,346
+2,204
| +20% | +$61.7K | 0.06% | 156 |
|
|
2024
Q1 | $309K | Buy |
11,142
+547
| +5% | +$15.2K | 0.05% | 177 |
|
|
2023
Q4 | $305K | Sell |
10,595
-3,320
| -24% | -$95.6K | 0.06% | 166 |
|
|
2023
Q3 | $462K | Sell |
13,915
-2,533
| -15% | -$84K | 0.11% | 113 |
|
|
2023
Q2 | $603K | Buy |
16,448
+4,680
| +40% | +$172K | 0.14% | 96 |
|
|
2023
Q1 | $480K | Sell |
11,768
-560
| -5% | -$22.8K | 0.12% | 107 |
|
|
2022
Q4 | $632K | Buy |
12,328
+3,376
| +38% | +$173K | 0.18% | 81 |
|
|
2022
Q3 | $392K | Sell |
8,952
-1,664
| -16% | -$72.9K | 0.14% | 99 |
|
|
2022
Q2 | $557K | Buy |
10,616
+525
| +5% | +$27.5K | 0.21% | 74 |
|
|
2022
Q1 | $536K | Buy |
10,091
+49
| +0.5% | +$2.6K | 0.18% | 89 |
|
|
2021
Q4 | $530K | Buy |
10,042
+1,196
| +14% | +$63.1K | 0.19% | 87 |
|
|
2021
Q3 | $380K | Buy |
8,846
+1,428
| +19% | +$61.3K | 0.15% | 98 |
|
|
2021
Q2 | $290K | Buy |
7,418
+468
| +7% | +$18.3K | 0.12% | 102 |
|
|
2021
Q1 | $267K | Buy |
6,950
+125
| +2% | +$4.8K | 0.12% | 106 |
|
|
2020
Q4 | $251K | Sell |
6,825
-75
| -1% | -$2.76K | 0.13% | 102 |
|
|
2020
Q3 | $252K | Buy |
6,900
+305
| +5% | +$11.1K | 0.16% | 97 |
|
|
2020
Q2 | $216K | Sell |
6,595
-473
| -7% | -$15.5K | 0.17% | 108 |
|
|
2020
Q1 | $231K | Buy |
7,068
+31
| +0.4% | +$1.01K | 0.25% | 92 |
|
|
2019
Q4 | $276K | Buy |
+7,037
| New | +$276K | 0.27% | 90 |
|